SOUTH SAN FRANCISCO, Calif., April 01, 2025 (GLOBE NEWSWIRE) — Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural killer (NK) cell therapies, today announced its participation in the following investor conference:
| 24th Annual Needham Virtual Healthcare Conference |
| April 8, 2025 |
| 11:00 a.m. ET – fireside chat |
A simultaneous webcast of the event will be available on the Investors section of Nkarta’s website, www.nkartatx.com, and a replay will be archived on the website for approximately 90 days.
About Nkarta
Nkarta is a clinical-stage biotechnology company advancing the development of allogeneic, off-the-shelf natural killer (NK) cell therapies for autoimmune diseases. By combining its cell expansion and cryopreservation platform with proprietary cell engineering technologies and CRISPR-based genome engineering capabilities, Nkarta is building a pipeline of future cell therapies engineered for deep therapeutic activity and intended for broad access in the outpatient treatment setting. For more information, please visit the company’s website at www.nkartatx.com.
Nkarta Media/Investor Contact:
Nadir Mahmood
Nkarta, Inc.
nmahmood@nkartatx.com
SANTA CLARA, Calif.--(BUSINESS WIRE)--FemDx Medsystems, a pioneering medical device company focused on advancing gynecological diagnostics,…
New resources add value through seamless integration into Epic EHR and MyChart, streamlining care team…
Brokers, agents, and advisors invited to learn about technology integrations, eligibility and communications resources, and…
CHICAGO, April 28, 2025 /PRNewswire/ -- New research published in Cancer Research and presented today at the AACR…
New, online tool provides interactive and visual access to board certification data CHICAGO, April 28,…
New Role Highlights Pager Health's Supportive Partnership with Health Plans to Provide Scalable and Efficient…
![](data:image/svg+xml;charset=utf-8,<svg height="32px" width="32px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
![](data:image/svg+xml;charset=utf-8,<svg height="1px" width="1px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
